(Q40803409)

23 September 2017

title

Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains (English)

1 reference

23 September 2017

Gelus N

1

1 reference

23 September 2017

Bailly C

2

1 reference

23 September 2017

Hamy F

3

1 reference

23 September 2017

Klimkait T

4

1 reference

23 September 2017

Wilson WD

5

1 reference

23 September 2017

Boykin DW

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Bioorganic & Medicinal Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

7

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

1089-1096

1 reference

Dicationic diarylfurans as anti-Pneumocystis carinii agents

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

2,5-bis[4-(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Targeting the minor groove of DNA: crystal structures of two complexes between furan derivatives of berenil and the DNA dodecamer d(CGCGAATTCGCG)2

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Small changes in cationic substituents of diphenylfuran derivatives have major effects on the binding affinity and the binding mode with RNA helical duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

1 reference

7 January 2021

A Structural Basis for RNAminus signLigand Interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Design and analysis of molecular motifs for specific recognition of RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Control of RNA initiation and elongation at the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

RNA degradation by bleomycin, a naturally occurring bioconjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Characterization of iron (II).bleomycin-mediated RNA strand scission

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

Fe.bleomycin as a probe of RNA conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

RNA recognition by the human immunodeficiency virus Tat and Rev proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2899%2900041-3

7 January 2021

10.1016/S0968-0896(99)00041-3

Identifiers

DOI

1 reference

23 September 2017

1 reference